Cost-effectiveness of adjunctive eptifibatide in patients undergoing coronary stenting in Germany

Objective: To determine the cost-effectiveness of adding eptifibatide to the standard treatment for selected high-risk patients undergoing coronary stenting in Germany. Furthermore, to investigate the impact of several extrapolation methods on the results.